How should a 5‑day‑old newborn with a first episode of upward eye‑rolling, brief drowsiness, and a blood glucose of 56 mg/dL be evaluated and managed?

Immediate Management of Suspected Neonatal Seizure with Hypoglycemia

This 5-day-old infant requires immediate evaluation for neonatal seizure, urgent glucose monitoring with treatment if confirmed low, and comprehensive workup for persistent hypoglycemia disorder—particularly hyperinsulinism—given the concerning neurologic symptoms at day 5 of life.

Critical Initial Actions

The upward eye-rolling with altered consciousness represents a potential seizure event, which in the context of a glucose of 56 mg/dL at 5 days of age is highly concerning. While 56 mg/dL might fall within transitional hypoglycemia ranges in the first 0-4 hours of life (mean 57 mg/dL) 1, at day 5, glucose should be in the normal adult range (mean 82 mg/dL by 72-96 hours) 1. This represents persistent hypoglycemia, not transitional.

Immediate Steps:

• Recheck blood glucose immediately to confirm current level
• If glucose <50 mg/dL or symptomatic at any level: Give IV dextrose bolus (200 mg/kg = 2 mL/kg of D10W) followed by continuous infusion
• If glucose 50-70 mg/dL and asymptomatic now: Attempt feeding with close monitoring, but maintain very low threshold for IV dextrose given the recent neurologic event
• Obtain critical sample before treating if possible: glucose, insulin, beta-hydroxybutyrate, free fatty acids, cortisol, growth hormone, lactate

Why This Is High-Risk

Hyperinsulinism is the most common cause of persistent neonatal hypoglycemia and carries the highest risk of neurocognitive dysfunction because:

1. The hypoglycemia is typically severe
2. The brain cannot generate ketones as alternative fuel 1
3. Neurologic injury risk is substantial with delayed diagnosis 1

The fact that this infant had a neurologic event (potential seizure) at day 5 with documented hypoglycemia suggests this is NOT benign transitional hypoglycemia.

Essential Diagnostic Workup

Critical sample interpretation (obtained during hypoglycemia <50 mg/dL ideally):

• Hyperinsulinism: Detectable insulin (>2 μU/mL), low ketones, low free fatty acids, glucose requirement >8-10 mg/kg/min
• Cortisol deficiency: Cortisol <18 μg/dL during hypoglycemia
• Growth hormone deficiency: GH <10 ng/mL during hypoglycemia
• Metabolic disorders: Elevated lactate, abnormal acylcarnitine profile

Additional Testing:

• Continuous glucose monitoring or frequent checks (every 1-2 hours initially)
• Neurologic evaluation including EEG if seizure suspected
• Brain MRI if seizures confirmed or persistent hypoglycemia documented (to assess for injury)

Treatment Algorithm

For symptomatic hypoglycemia (seizure-like activity):

1. IV dextrose bolus immediately
2. Start continuous dextrose infusion (6-8 mg/kg/min, titrate up as needed)
3. If requiring >12-15 mg/kg/min → strongly suggests hyperinsulinism
4. Consider glucagon 0.5-1 mg IM as temporizing measure if IV access delayed

For confirmed hyperinsulinism:

• Diazoxide as first-line therapy
• Octreotide if diazoxide-unresponsive
• Urgent pediatric endocrinology consultation
• Possible surgical evaluation if medication-refractory

Critical Pitfalls to Avoid

1. Do not dismiss this as "transitional hypoglycemia" at day 5 of life—transitional hypoglycemia resolves by 72-96 hours 1
2. Do not delay workup waiting for recurrent events—the initial seizure-like episode with documented hypoglycemia is sufficient indication
3. Do not discharge without complete evaluation—guidelines emphasize completing evaluations prior to hospital discharge to prevent delayed diagnoses and neurologic damage 1
4. Do not rely solely on feeding in a symptomatic infant—this requires IV dextrose

Screening Context

While guidelines recommend screening at-risk neonates 2, 3, 4, this infant has moved beyond screening—this is diagnostic evaluation for persistent hypoglycemia disorder with neurologic symptoms. The convergence of all guidelines on immediate treatment of symptomatic hypoglycemia 3 makes this a clear-cut case requiring aggressive intervention.

The infant feeding actively after the event does not exclude serious pathology—many infants with hyperinsulinism have intermittent symptoms between hypoglycemic episodes.